Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Articles

Check out our top five most engaged social media posts from the year 2024.

Our Top 5 Social Media Posts of 2024

The top five episodes of our podcast in the year 2024, highlighted. 

Our Top 5 Podcast Episodes of 2024

. He can be reached at nsaraceno@mjhlifesciences.com.

The latest in container tech and temperature-monitoring truly powered the content. 

Popular DSCSA Pieces Throughout the Year

The latest news for pharma industry insiders.

Pharma Pulse 12/24/24: How Telehealth and Pharma are Partnering to Revolutionize Healthcare, The Influence of Vaping on Smoking Cessation & more

Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia. 

Trade & Channel Strategies 2024: Navigating Industry Challenges

How will supply chains in the space continue to develop?

Forecasting the 2025 Healthcare Logistics Space

Pharma Pulse 12/23/24: Impact of DEA Telehealth Extensions, Big Jump in US Healthcare Spending & more

Videos

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the difference between return on invested capital in pharma compared to other organizations. 

Trade & Channel Strategies 2024: The Significance of Return on Invested Capital for Pharma Companies

In the fifth part of this roundtable discussion, subject matter experts discuss the role that various GS1 initiatives have played, and provide a breakdown of stakeholders who have benefitted greatly from RFID.

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead